日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update

晚期未经治疗的滤泡性淋巴瘤患者接受为期六个月的利妥昔单抗-来那度胺方案治疗:SAKK 35/10 试验 10 年随访更新

Kimby, Eva; Schär, Sämi; Pirosa, Maria Cristina; Vanazzi, Anna; Mey, Ulrich M; Rauch, Daniel; Wahlin, Björn E; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés José María; Krasniqi, Fatime; Voegeli, Michèle; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Mamot, Christoph; Mingrone, Walter; Stathis, Anastasios; Dirnhofer, Stefan; Hayoz, Stefanie; Østenstad, Bjørn; Zucca, Emanuele

Fluorescence correlation spectroscopy for particle sizing: A notorious challenge

荧光相关光谱法测定粒径:一项臭名昭著的挑战

Krohn, Jan-Hagen; Mamot, Adam; Kaletta, Nastasja; Qutbuddin, Yusuf; Schwille, Petra

Re-irradiation for recurrent glioblastoma: a pattern of care analysis

复发性胶质母细胞瘤的再次放疗:治疗模式分析

Rogers, Susanne; Gross, Markus; Ermis, Ekin; Cosgun, Gizem; Baumert, Brigitta G; Mader, Thomas; Schroeder, Christina; Lomax, Nicoletta; Alonso, Sara; Ademaj, Adela; Lazeroms, Tessa; Lee, Seok-Yun; Mayinger, Michael; Mamot, Christoph; Schwyzer, Lucia; Schubert, Gerrit A; Riesterer, Oliver

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

REMoDL-B研究中,根据分子亚组分析,在弥漫性大B细胞淋巴瘤的R-CHOP方案中加入硼替佐米的疗效存在差异,随访时间为5年。

Davies, Andrew J; Barrans, Sharon; Stanton, Louise; Caddy, Josh; Wilding, Sam; Saunders, Geoff; Mamot, Christoph; Novak, Urban; McMillan, Andrew; Fields, Paul; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Sha, Chulin; van Hoppe, Moniek; Tooze, Reuben; Davies, John R; Griffiths, Gareth; Schuh, Anna; Burton, Catherine; Westhead, David R; Du, Ming-Qing; Johnson, Peter W M

Chemical Modifications of mRNA Ends for Therapeutic Applications

mRNA 末端化学修饰在治疗中的应用

Marcin Warminski, Adam Mamot, Anaïs Depaix, Joanna Kowalska, Jacek Jemielity

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

一项针对晚期三阴性乳腺癌患者的多中心II期临床试验,研究载有阿霉素的抗EGFR免疫脂质体的疗效

Mamot, Christoph; Wicki, Andreas; Hasler-Strub, Ursula; Riniker, Salome; Li, Qiyu; Holer, Lisa; Bärtschi, Daniela; Zaman, Khalil; von Moos, Roger; Dedes, Konstantin J; Boos, Laura A; Novak, Urban; Bodmer, Alexandre; Ritschard, Reto; Obermann, Ellen C; Tzankov, Alexandar; Ackermann, Christoph; Membrez-Antonioli, Véronique; Zürrer-Härdi, Ursina; Caspar, Clemens B; Deuster, Stefanie; Senn, Martin; Winterhalder, Ralph; Rochlitz, Christoph

Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study

非鳞状晚期非小细胞肺癌患者联合免疫化疗的真实世界数据:一项单中心回顾性研究

Wallrabenstein, Till; Mamot, Maximilian; Daetwyler, Eveline; König, David; Rothschild, Sacha I

Ethylenediamine derivatives efficiently react with oxidized RNA 3' ends providing access to mono and dually labelled RNA probes for enzymatic assays and in vivo translation

乙二胺衍生物能与氧化的RNA 3'末端高效反应,从而可制备单标记和双标记的RNA探针,用于酶活性测定和体内翻译。

Mamot, Adam; Sikorski, Pawel J; Siekierska, Aleksandra; de Witte, Peter; Kowalska, Joanna; Jemielity, Jacek

Targeting immunoliposomes to EGFR-positive glioblastoma

将免疫脂质体靶向 EGFR 阳性胶质母细胞瘤

B Kasenda, D König, M Manni, R Ritschard, U Duthaler, E Bartoszek, A Bärenwaldt, S Deuster, G Hutter, D Cordier, L Mariani, J Hench, S Frank, S Krähenbühl, A Zippelius, C Rochlitz, C Mamot, A Wicki, H Läubli

Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study

基线代谢参数和突变谱的整合可预测弥漫性大B细胞淋巴瘤患者一线治疗的长期疗效:SAKK38/07研究的事后分析

Genta, Sofia; Ghilardi, Guido; Cascione, Luciano; Juskevicius, Darius; Tzankov, Alexandar; Schär, Sämi; Milan, Lisa; Pirosa, Maria Cristina; Esposito, Fabiana; Ruberto, Teresa; Giovanella, Luca; Hayoz, Stefanie; Mamot, Christoph; Dirnhofer, Stefan; Zucca, Emanuele; Ceriani, Luca